STRO-001 / Sutro Biopharma, BioNova Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
STRO-001 / Sutro Biopharma
NCT05611853: Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Terminated
1/2
9
RoW
BN301, STRO-001
BioNova Pharmaceuticals (Shanghai) LTD.
B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
12/23
12/23

Download Options